Ontology highlight
ABSTRACT: Objective
Acute and subacute toxicity analysis of AND-2-HyP-β-CYD complex was conducted in Sprague-Dawley (SD) rats following oral and inhalation routes of administration.Methods and results
Single dose acute toxicity was carried out at 2000 mg/kg of AND-2-HyP-β-CYD complex, while the doses of 200, 400, and 666 mg/kg were administered, over a period of 28 days under repeated dose oral toxicity study. Hence, LD50 (lethal dose) was found to be >2000 mg/kg in addition to NOAEL (no observed adverse effect level) of 666 mg/kg. Correspondingly, single dose acute inhalation toxicity of AND-2-HyP-β-CYD complex was carried out at 5 mg/L/4 h/day and subacute inhalation toxicity at 0.5, 1, and 1.66 mg/L/4 h/day over a period of 28 days. The NOAEL and LOAEL (lowest observed adverse effect level) were estimated to be 0.5 mg/L/4 h/day and 1 mg/L/4 h/day, respectively.Conclusion
The findings of the present study would further be useful in assessing and utilizing the medicinal and therapeutic benefits of AND-2-HyP-β-CYD complex.
SUBMITTER: Chandrama Singh S
PROVIDER: S-EPMC8979680 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
Chandrama Singh Shashi S Choudhary Muskan M Mourya Atul A Khatri Dharmendra Kumar DK Singh Pankaj Kumar PK Madan Jitender J Singh Harshpal H
TheScientificWorldJournal 20220328
<h4>Objective</h4>Acute and subacute toxicity analysis of AND-2-HyP-<i>β</i>-CYD complex was conducted in Sprague-Dawley (SD) rats following oral and inhalation routes of administration.<h4>Methods and results</h4>Single dose acute toxicity was carried out at 2000 mg/kg of AND-2-HyP-<i>β</i>-CYD complex, while the doses of 200, 400, and 666 mg/kg were administered, over a period of 28 days under repeated dose oral toxicity study. Hence, LD50 (lethal dose) was found to be >2000 mg/kg in addition ...[more]